Evidence map›Paper›PMID 28124823›Full record

ArticleChemSusChem2017

Synthesis of Furandicarboxylic Acid Esters From Nonfood Feedstocks Without Concomitant Levulinic Acid Formation.

Frits van der Klis, Jacco van Haveren, Daan S van Es, Johannes H Bitter

Open access · hybridAbstract read
In one paragraph

Article in ChemSusChem, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 32 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. Catalytic Oxidations in a Bio-Based Economy.Frontiers in chemistry · 2020
    Review
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Frits van der KlisWageningen University Biobased Chemistry and Technology, Bornse Weilanden 9, 6708WG, Wageningen, The Netherlands.
Jacco van HaverenWageningen Food & Biobased Research, Bornse Weilanden 9, 6708WG, Wageningen, The Netherlands.
Daan S van EsWageningen Food & Biobased Research, Bornse Weilanden 9, 6708WG, Wageningen, The Netherlands.
Johannes H BitterWageningen University Biobased Chemistry and Technology, Bornse Weilanden 9, 6708WG, Wageningen, The Netherlands.
Wageningen University & Research · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

5-Hydroxymethylfurfural (HMF) is a versatile intermediate in biomass conversion pathways. However, the notoriously unstable nature of HMF imposes challenges to design selective routes to chemicals such as furan-2,5-dicarboxylic acid (FDCA). Here, a new strategy for obtaining furans is presented, bypassing the formation of the unstable HMF. Instead of starting with glucose/fructose and thus forming HMF as an intermediate, the new route starts from uronic acids, which are abundantly present in many agro residues such as sugar beet pulp, potato pulp, and citrus peels. Conversion of uronic acids, via ketoaldonic acids, to the intermediate formylfuroic acid (FFA) esters, and subsequently to FDCA esters, proceeds without formation of levulinic acid or insoluble humins. This new route provides an attractive strategy to valorize agricultural waste streams and a route to furanic building blocks without the co-production of levulinic acid or humins.

Indexed as

CatalysisChemistry Techniques, SyntheticDicarboxylic AcidsEstersFuransIsomerismLevulinic AcidsOxidation-ReductionSolvents2,5-furandicarboxylic acidDicarboxylic AcidsEstersFuranslevulinic acidLevulinic AcidsSolventsfurandicarboxylic acidisomerizationlevulinic acidoxidationuronic acids

Identifiers

PMID28124823
PMCPMC5413837
OpenAlexW2581907644

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.